The first central precocious puberty proteomic profiles revealed multiple metabolic networks and novel key

Chunlin Wang1, Qingqing Chen1, Ke Yuan1

  • 1Department of Pediatrics, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.

Aging
|November 8, 2021
PubMed

Insights

Central precocious puberty (CPP) affects child development, yet treatments are outdated. This study identifies novel metabolic targets for potential new therapies by analyzing CPP

Area of Science:

  • Endocrinology
  • Metabolomics
  • Systems Biology

Background:

  • Central precocious puberty (CPP) is a condition impacting child development with limited therapeutic options.
  • Current treatments for CPP have not advanced significantly since the 1980s.
  • The complex pathogenesis of CPP necessitates advanced research approaches.

Purpose of the Study:

  • To investigate the proteomic profile of central precocious puberty using a systems biology approach.
  • To identify novel molecular factors and pathways implicated in CPP pathogenesis.
  • To explore potential new therapeutic targets for CPP.

Main Methods:

  • Proteomic profiling of central precocious puberty (CPP) patients.
  • Differential protein expression analysis.
  • Bioinformatic enrichment analysis of altered proteins in metabolic pathways.

Main Results:

  • The study established the first proteome profile for CPP.
  • Identified 163 down-regulated and 129 up-regulated differentially expressed proteins.
  • Altered proteins were significantly enriched in energy, amino acid, and nitrogenous base metabolism.

Conclusions:

  • The proteomic alterations in CPP highlight the role of metabolic dysregulation.
  • Identified metabolic signaling pathways offer potential novel therapeutic targets for CPP.
  • This research provides a foundation for developing advanced treatments for central precocious puberty.